Data form TARA trial Taper in RA remission Flare free survival at 2 yrs 35% Risk of flare is similar in ACPA+ & ACPA
Tweet Content
Data form TARA trial Taper in RA remission
Flare free survival at 2 yrs 35%
Risk of flare is similar in ACPA+ & ACPA- RA
Risk of flare is similar if taper TNFi first or csDMARD first
@RheumNow #EULAR2024 POS0405 https://t.co/89gAglHUcw
Show on Archive Page
On
Display in Search Results
On
PDQ
Off